Paid Clinical Trials Vancouver

Discover 695 paid clinical trials in Vancouver, British Columbia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 695

Observational StudyProstate Active Surveillance Study

Recruiting

Sponsor:

University of Washington

Location:

Vancouver, Seattle WA, San Francisco CA, Stanford CAshow 5 more

Code:

NCT00756665

Conditions

Prostatic Neoplasms

Eligibility Criteria

Sex: Male

Age: 21+

Healthy Volunteers: Not accepted

Daratumumab vs. DaratumumabFixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Vancouver, Kelowna, Saskatoon, Reginashow 16 more

Code:

NCT06182774

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Daratumumab

Lenalidomide

Dexamethasone

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Vancouver, Seattle WA, West Jordan UT, Sandy UTshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Telmisartan vs. PerindoprilTelmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Recruiting

PHASE2

Sponsor:

Sunnybrook Health Sciences Centre

Location:

Vancouver, Calgary, Lethbridge, Londonshow 2 more

Code:

NCT02085265

Conditions

Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Perindopril

Telmisartan

Genomic Biomarker-SelectedGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Recruiting

PHASE2

Sponsor:

University of British Columbia

Location:

Vancouver, Seattle WA, Sacramento CA, Ann Arbor MIshow 5 more

Code:

NCT04812366

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apalutamide 60mg Tab

Abiraterone Acetate 250mg

Prednisone 5mg Tab

Docetaxel

Niraparib 100mg Oral Capsule

[Ac-225]-PSMA-62[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Recruiting

PHASE1

Sponsor:

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Location:

Vancouver, Hamilton, Toronto, Montrealshow 2 more

Code:

NCT06229366

Conditions

Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Oligometastatic Prostate Carcinoma

Hormone Sensitive Prostate Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

[Ac-225]-PSMA-62 (mCRPC)

[Ac-225]-PSMA-62 (OmHSPC)

Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

Recruiting

PHASE3

Sponsor:

University of Leicester

Location:

Vancouver, Seattle WA, Tacoma WA, Portland ORshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

Observational StudyRegistry for Patients Receiving Intravenous Nutrition at Home

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Vancouver, Calgary, Edmonton, Reginashow 5 more

Code:

NCT02299466

Conditions

Parenteral Nutrition, Home

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

CamizestrantAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

North Vancouver, Puyallup WA, Kelowna, Vancouver WAshow 143 more

Code:

NCT05952557

Conditions

Breast Cancer, Early Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Camizestrant

Tamoxifen

Anastrozole

Letrozole

Exemestane

BMS-986278A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Vancouver, Everett WA, Seattle WA, Kelownashow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo